Pentoxifylline for alcoholic hepatitis

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2008, Pages

  Whitfield, Kate ^a   Rambaldi, Andrea ^a   Gluud, Christian ^a  

^a University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PENTOXIFYLLINE; PLACEBO;

ALCOHOL LIVER DISEASE; CLINICAL TRIAL; DATA ANALYSIS; DATA EXTRACTION; HUMAN; INFORMATION PROCESSING; OUTCOME ASSESSMENT; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

EID: 55049086277     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007339     Document Type: Review

References (34)

1. Akriviadis 2000 Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;199:1637-48.
2. Begg 1994 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088- 1101.
3. Brok 2008 Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;Apr 12:[Epub ahead of print]. [DOI: 10.1016/j.jclinepi.2007.10.007]
4. Ceccanti 2006 Ceccanti M, Attili A, Balducci G, Attilia F, Giacomelli S, Rotondo C, et al.Acute alcoholic hepatitis. Journal of Clinical Gastroenterology 2006;40:833-41.
5. Christensen 1995 Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995;37(1):113-8. [MEDLINE: 1995402786]
6. DeMets 1987 DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
7. DerSimonian 1986 DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88.
8. Egger 1997 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed) 1997;315:629-34.
9. Gluud 2001 Gluud C. Alcoholic hepatitis: no glucocorticosteroids?. FALK Symposium 121. Steatohepatitis (NASH and ASH) 2001; Vol. 121:400.
10. Gluud 2008 Gluud C, Nikolova D, Klingenberg SL, Whitfield K, Alexakis N, Als-Nielsen B, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)) 2008, Issue 3. Art. No.: LIVER.
11. Hardison 1966 Hardison WG, Lee FI. Prognosis in acute liver disease of alcoholic patients. New England Journal of Medicine 1966;275:61-6.
12. Higgins 2002 Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
13. Higgins 2008 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochranehandbook. org.
14. ICH-GCP 1996 International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Guideline for Good Clinical Practice. E6 (R1). ICHHarmonised Tripartite Guideline 1996.
15. Imperiale 1990 Imperiale F, McCullough AJ. Do corticosteroids reduce mortality fromalcoholic hepatitis?. Annals of Internal Medicine 1990;113:299-307.
16. Kjaergard 2001 Kjaerdard LL, Villumsen J, Gluud C. Reportedmethodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135:982-9.
17. Lebrec 2007 Lebrec D, Thabut D, Oberti F, Perarnau JM, Condat B, Barraud H, et al. Pentoxifylline for the treatment of patients with advanced cirrhosis. A randomized, placebo-controlled, double-blind trial. Hepatology 2007;46 Suppl 1(4):249A-250A.
18. Levistsky 2004 Levistsky J, Mailliard ME. Diagnosis and therapy of alcoholic liver disease. Seminars in Liver Disease 2004;24(3): 233-46.
19. Maddrey 1978 Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75:193-9.
20. Madhotra 2003 Madhotra R, Gilmore IT. Recent developments in the treatment of alcoholic hepatitis. Oxford Journal of Medicine 2003;96:391-400.
21. McClain 1989 McClain CJ, Cohen DA. Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 1989;9:349-51.
22. McCullough 1998 McCullough AJ, O'Connor JF. Alcoholic liver disease: proposed recommendations for the American College of Gastroenterology. The American Journal of Gastroenterology 1998;93(11):2022-36.
23. McHutchison 1991 McHutchison JG, Runyon BA, Draguesku JO, Cominelli F, Person JL, Castracance J. Pentoxifylline may prevent renal impairment (hepatorenal syndrome) in severe acute alcoholic hepatitis. Hepatology 1991;14 Pt 2(4):96A.
24. Moher 1998 Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. The Lancet 1998;352:609-13.
25. Poynard 1991 Poynard T, Ramond MJ, Reuff B, Mathurin P, Theodore C, et al. Corticosteroid therapy reduces mortality from alcoholic hepatitis in patients without encephalopathy. A meta-analysis of randomized trials (RCTs) including French trials. Hepatology 1991;14:234A.
26. Rambaldi 2009 Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Glucocorticosteroids for alcoholic hepatitis. Cochrane Database of Systematic Reviews, In editorial phase. [Art.No.: CD001511. DOI: 10.1002/14651858.CD001511]
27. RevMan 2008 Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
28. Rongey 2006 Rongey C, Kaplowitz N. Current concepts and controversies in the treatment of alcoholic hepatitis. World Journal of Gastroenterology 2006;12:6909-21.
29. Royle 2003 Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
30. Rücker 2008 Rücker G, Schwarzer G, Carpenter J. Arcsine test for publication bias in meta-analyses with binary outcomes. Statistics in Medicine 2008;27(5):746-63.
31. Schulz 1995 Schultz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions ofmethodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-12.
32. Sidhu 2006 Sidhu S, Singla M, Bhatia KL. Pentoxifylline reduces disease severity and prevents renal impairment in severe acute alcoholic hepatitis: a double blind, placebo controlled trial. Hepatology 2006;44 Suppl 4 (1):373A.
33. Wetterslev 2008 Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75.
34. Wood 2008 Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed) 2008;336(7644):601-5.